NEW YORK (GenomeWeb) – Oregon Health & Science University (OHSU) and Swedish diagnostics firm Immunovia today announced a collaboration on a diagnostic test for the early detection of pancreatic cancer.

Under the terms of the agreement, the partners will confirm, validate, and commercialize the Immray PanCan-d blood test. A retrospective study using patients samples from OHSU's Brenden-Colson Center for Pancreatic Care will seek to confirm earlier results from studies in Europe and China with a US population. The partners will also explore biomarkers for other cancer types.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.